Genetic regulation of fibrin structure and function: Complex gene-environment interactions may modulate vascular risk

Lancet

Volumn 361, Issue 9367, 2003, Pages 1424-1431

  Lim, Bernard C B ^a,b   Ariëns, Robert A S ^a   Carter, Angela M ^a   Weisel, John W ^b   Grant, Peter J ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; FIBRINOGEN A ALPHA; LEUCINE; THREONINE; UNCLASSIFIED DRUG; VALINE;

AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FIBRIN FORMATION; FIBRIN POLYMERIZATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC REGULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; CEREBROVASCULAR ACCIDENT; GENETICS; GENOTYPE; MOLECULAR BIOLOGY; RISK FACTOR; STATISTICAL MODEL;

AGED; CEREBROVASCULAR ACCIDENT; FACTOR XIII; FEMALE; FIBRINOGEN; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR BIOLOGY; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0242348804     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13135-2     Document Type: Article

References (30)

1. Kohler H.P., Stickland M.H., Ossei-Gerning N., Carter A.M., Mikkola H., Grant P.J. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost. 79:1998;8-13.
2. Wartiovaara U., Perola M., Mikkola H., et al. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis. 142:1999;295-300.
3. Elbaz A., Poirier O., Canaple S., Chedru F., Cambien F., Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood. 95:2000;586-591.
4. Warner D., Mansfield M.W., Grant P.J. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost. 85:2001;408-411.
5. Corral J., Gonzalez-Conejero R., Iniesta J.A., Rivera J., Martinez C., Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica. 85:2000;293-297.
6. Ariens R.A.S., Philippou H., Nagaswami C., Weisel J.W., Lane D.A., Grant P.J. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 96:2000;988-995.
7. Behague I., Poirier O., Nicaud V., et al. β fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. Circulation. 93:1996;440-449.
8. Carter A.M., Catto A.J., Grant P.J. Association of the α-fibrinogen Thr312Ala polymorphism with post-stroke mortality in subjects with atrial fibrillation. Circulation. 99:1999;2423-2426.
9. Meade T.W., Mellows S., Brozovic M., et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 2:1986;533-537.
10. Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 311:2001;501-505.
11. Fatah K., Silveira A., Tornvall P., Karpe F., Blomback M., Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost. 76:1996;535-540.
12. Fatah K., Hamsten A., Blomback B., Blomback M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost. 68:1992;130-135.
13. Collet J.P., Soria J., Mirshahi M., et al. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability - hypofibrinolysis related to an abnormal clot structure. Blood. 82:1993;2462-2469.
14. Carter A.M., Catto A.J., Bamford J.M., Grant P.J. Gender-specific associations of the fibrinogen Bβ 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol. 17:1997;589-594.
15. Catto A.J., Kohler H.P., Bannan S., Stickland M.H., Carter A.M., Grant P.J. Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke. 29:1998;813-816.
16. Catto A.J., Kohler H.P., Coore J., Mansfield M.W., Stickland M.H., Grant P.J. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood. 93:1999;906-908.
17. Baumann R.E., Henschen A.H. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at A α 312 and B β 448. Blood. 82:1993;2117-2124.
18. Woodhead J.L., Nagaswami C., Matsuda M., Arocha-Pinango C.L., Weisel J.W. The ultrastructure of fibrinogen Caracas II molecules, fibers and clots. J Biol Chem. 271:1996;4946-4953.
19. Weisel J.W., Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J. 63:1992;111-128.
20. Lane D.A., Grant P.J. Role of haemostatic gene sequence polymorphisms in venous and arterial disease. Blood. 95:2000;1-16.
21. Carter A.M., Catto A.J., Kohler H.P., Ariens R.A.S., Stickland M.H., Grant P.J. α Fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood. 96:2000;1177-1179.
22. Ma J., Hennekens C.H., Ridker P.M., Stampfer M.J. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol. 33:1999;1347-1352.
23. Bennett J.S. Platelet-fibrinogen interactions. Ann N Y Acad Sci. 936:2001;340-354.
24. Blomback B., Carlsson K., Hessel B., Liljeborg A., Procyck R., Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 997:1989;96-110.
25. Collet J.P., Park D., Lesty C., et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed/dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 20:2000;1354-1361.
26. Gemmati D., Serino M.L., Ongaro A. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol. 67:2001;183-188.
27. Tuut M., Hense H.W. Smoking, other risk factors and fibrinogen levels. Evidence of effect modification. Ann Epidemiol. 11:2001;232-238.
28. Hunter K.A., Garlick P.J., Broom I., Anderson S.E., McNurlan M.A. Effects of smoking and abstention from smoking on fibrinogen synthesis in humans. Clin Sci. 100:2001;459-465.
29. Dotevall A., Johansson S., Wilhelmsen L. Association between fibrinogen and other risk factors for cardiovascular disease in men and women: results from the Goteborg MONICA survey 1985. Ann Epidemiol. 4:1994;369-374.
30. Franco R.F., Pazin-Filho A., Tavella A.H., Simoes M.V., Marin-Neto J.A., Zago M.A. Factor XIII Val34Leu and the risk of myocardial infarction. Haematologica. 85:2000;67-71.